Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 431

1.

A multiscale agent-based model of ductal carcinoma in situ.

Butner JD, Fuentes D, Ozpolat B, Calin GA, Zhou X, Lowengrub J, Cristini V, Wang Z.

IEEE Trans Biomed Eng. 2019 Oct 8. doi: 10.1109/TBME.2019.2938485. [Epub ahead of print]

PMID:
31603768
2.

Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey.

Crudden C, Song D, Cismas S, Trocmé E, Pasca S, Calin GA, Girnita A, Girnita L.

Cells. 2019 Oct 9;8(10). pii: E1223. doi: 10.3390/cells8101223. Review.

3.

Current concepts of non-coding RNA regulation of immune checkpoints in cancer.

Smolle MA, Prinz F, Calin GA, Pichler M.

Mol Aspects Med. 2019 Sep 30. pii: S0098-2997(19)30083-4. doi: 10.1016/j.mam.2019.09.007. [Epub ahead of print] Review.

PMID:
31582259
4.

MiR-200 family and cancer: From a meta-analysis view.

Huang GL, Sun J, Lu Y, Liu Y, Cao H, Zhang H, Calin GA.

Mol Aspects Med. 2019 Sep 23. pii: S0098-2997(19)30061-5. doi: 10.1016/j.mam.2019.09.005. [Epub ahead of print] Review.

PMID:
31558294
5.

The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.

Li Y, Chen M, Pardini B, Dragomir MP, Lucci A, Calin GA.

J Transl Med. 2019 Sep 23;17(1):318. doi: 10.1186/s12967-019-2069-y.

6.

GLS2 is protumorigenic in breast cancers.

Dias MM, Adamoski D, Dos Reis LM, Ascenção CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMG.

Oncogene. 2019 Sep 20. doi: 10.1038/s41388-019-1007-z. [Epub ahead of print]

PMID:
31541193
7.

The non-coding RNome after splenectomy.

Dragomir MP, Tudor S, Okubo K, Shimizu M, Chen M, Giza DE, He WR, Ivan C, Calin GA, Vasilescu C.

J Cell Mol Med. 2019 Sep 8. doi: 10.1111/jcmm.14664. [Epub ahead of print]

8.

Highlighting transcribed ultraconserved regions in human diseases.

Pereira Zambalde E, Mathias C, Rodrigues AC, de Souza Fonseca Ribeiro EM, Fiori Gradia D, Calin GA, Carvalho de Oliveira J.

Wiley Interdiscip Rev RNA. 2019 Sep 5:e1567. doi: 10.1002/wrna.1567. [Epub ahead of print] Review.

PMID:
31489780
9.

Decrypting noncoding RNA interactions, structures, and functional networks.

Fabbri M, Girnita L, Varani G, Calin GA.

Genome Res. 2019 Sep;29(9):1377-1388. doi: 10.1101/gr.247239.118. Epub 2019 Aug 21.

10.

Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies.

Pardini B, Sabo AA, Birolo G, Calin GA.

Cancers (Basel). 2019 Aug 14;11(8). pii: E1170. doi: 10.3390/cancers11081170. Review.

11.

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.

Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA.

Gut. 2019 Jun 6. pii: gutjnl-2018-318070. doi: 10.1136/gutjnl-2018-318070. [Epub ahead of print]

12.

MicroRNA based theranostics for brain cancer: basic principles.

Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP.

J Exp Clin Cancer Res. 2019 May 29;38(1):231. doi: 10.1186/s13046-019-1180-5. Review.

13.

The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors.

Bayraktar R, Bertilaccio MTS, Calin GA.

Front Immunol. 2019 May 14;10:1053. doi: 10.3389/fimmu.2019.01053. eCollection 2019. Review.

14.

Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.

Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY.

J Natl Cancer Inst. 2019 May 24. pii: djz097. doi: 10.1093/jnci/djz097. [Epub ahead of print]

PMID:
31124563
15.

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.

Li Z, Wong KY, Calin GA, Chng WJ, Chan GC, Chim CS.

Clin Epigenetics. 2019 May 7;11(1):71. doi: 10.1186/s13148-019-0669-2.

16.

MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer.

Pardini B, Calin GA.

Cancers (Basel). 2019 Mar 17;11(3). pii: E378. doi: 10.3390/cancers11030378. Review.

17.

Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer.

Farooqi AA, Fuentes-Mattei E, Fayyaz S, Raj P, Goblirsch M, Poltronieri P, Calin GA.

Semin Cancer Biol. 2019 Oct;58:47-55. doi: 10.1016/j.semcancer.2019.02.003. Epub 2019 Feb 8. Review.

PMID:
30742906
18.

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M.

Breast Cancer Res. 2019 Feb 1;21(1):20. doi: 10.1186/s13058-019-1104-5.

19.

The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.

Mokhlis HA, Bayraktar R, Kabil NN, Caner A, Kahraman N, Rodriguez-Aguayo C, Zambalde EP, Sheng J, Karagoz K, Kanlikilicer P, Abdel Aziz AAH, Abdelghany TM, Ashour AA, Wong S, Gatza ML, Calin GA, Lopez-Berestein G, Ozpolat B.

Mol Ther Nucleic Acids. 2019 Mar 1;14:301-317. doi: 10.1016/j.omtn.2018.11.019. Epub 2018 Dec 13.

20.

CRISPR-based RNA editing: diagnostic applications and therapeutic options.

Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.

Expert Rev Mol Diagn. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242. Epub 2019 Jan 21. No abstract available.

PMID:
30632384
21.

The noncoding RNA revolution-three decades and still going strong!

Calin GA.

Mol Oncol. 2019 Jan;13(1):3. doi: 10.1002/1878-0261.12418. No abstract available.

22.

The long noncoding RNA KIAA0125 is upregulated in ameloblastomas.

Diniz MG, França JA, Vilas-Boas FAS, de Souza FTA, Calin GA, Gomez RS, de Sousa SF, Gomes CC.

Pathol Res Pract. 2019 Mar;215(3):466-469. doi: 10.1016/j.prp.2018.12.030. Epub 2018 Dec 26.

PMID:
30595406
23.

Role of miRNAs in immune responses and immunotherapy in cancer.

Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA.

Genes Chromosomes Cancer. 2019 Apr;58(4):244-253. doi: 10.1002/gcc.22725. Review.

PMID:
30578699
24.

S-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell Persistence.

Mitra K, Feist WN, Anfossi S, Fuentes-Mattei E, Almeida MI, Kim JJ, Calin GA, Warmflash A.

ACS Synth Biol. 2019 Jan 18;8(1):25-33. doi: 10.1021/acssynbio.8b00406. Epub 2018 Dec 21.

PMID:
30550267
25.

miR-181a/b therapy in lung cancer: reality or myth?

Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I.

Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3. Review.

26.

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.

Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G.

EBioMedicine. 2018 Dec;38:100-112. doi: 10.1016/j.ebiom.2018.11.004. Epub 2018 Nov 25.

27.

Preface for GCC Special Issue on noncoding RNAs, noncoding DNAs, and genome editing.

Calin GA.

Genes Chromosomes Cancer. 2019 Apr;58(4):189-190. doi: 10.1002/gcc.22710. Epub 2019 Jan 7. No abstract available.

PMID:
30474323
28.

The involvement of microRNA in the pathogenesis of Richter syndrome.

Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA.

Haematologica. 2019 May;104(5):1004-1015. doi: 10.3324/haematol.2018.203828. Epub 2018 Nov 8.

29.

Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2019 Jan;38(5):765-766. doi: 10.1038/s41388-018-0560-1.

PMID:
30397238
30.

Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer.

Foßelteder J, Calin GA, Pichler M.

Expert Opin Ther Targets. 2018 Dec;22(12):973-976. doi: 10.1080/14728222.2018.1541453. Epub 2018 Oct 30. No abstract available.

PMID:
30365347
31.

Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.

Van Roosbroeck K, Bayraktar R, Calin GA.

Methods Mol Biol. 2019;1881:267-276. doi: 10.1007/978-1-4939-8876-1_20.

PMID:
30350212
32.

miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics.

Fu X, Calin GA.

EBioMedicine. 2018 Nov;37:17-18. doi: 10.1016/j.ebiom.2018.10.032. Epub 2018 Oct 15. No abstract available.

33.

Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs.

Dragomir M, Calin GA.

Front Oncol. 2018 Sep 21;8:307. doi: 10.3389/fonc.2018.00307. eCollection 2018.

34.

CpG island hypermethylation go circular (RNA).

Dragomir MP, Calin GA.

Oncotarget. 2018 Sep 4;9(69):33052-33053. doi: 10.18632/oncotarget.26074. eCollection 2018 Sep 4. No abstract available.

35.

The Non-Coding RNA Journal Club: Highlights on Recent Papers-6.

Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hubé F, Taube JH, Mani SA, Song L, Calin GA, Zhang S.

Noncoding RNA. 2018 Sep 18;4(3). pii: E23. doi: 10.3390/ncrna4030023.

36.

Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.

Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GA.

Mol Oncol. 2018 Nov;12(11):1856-1870. doi: 10.1002/1878-0261.12384. Epub 2018 Oct 15.

37.

New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?

Manga G, Calin GA, Manuc M, Droc G, Tudor S.

Chirurgia (Bucur). 2018 Jul-Aug;113(4):464-468. doi: 10.21614/chirurgia.113.4.464.

38.

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.

Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GA.

Sci Rep. 2018 Aug 30;8(1):13106. doi: 10.1038/s41598-018-30989-3.

39.

Exosomal lncRNAs as new players in cell-to-cell communication.

Dragomir M, Chen B, Calin GA.

Transl Cancer Res. 2018 Mar;7(Suppl 2):S243-S252. doi: 10.21037/tcr.2017.10.46.

40.

MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.

Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA.

Mol Aspects Med. 2018 Aug 17. pii: S0098-2997(18)30065-7. doi: 10.1016/j.mam.2018.07.003. [Epub ahead of print] Review.

PMID:
30102929
41.

SnapShot: Unconventional miRNA Functions.

Dragomir MP, Knutsen E, Calin GA.

Cell. 2018 Aug 9;174(4):1038-1038.e1. doi: 10.1016/j.cell.2018.07.040.

42.

Profiling the circulating miRnome reveals a temporal regulation of the bone injury response.

Silva AM, Almeida MI, Teixeira JH, Ivan C, Oliveira J, Vasconcelos D, Neves N, Ribeiro-Machado C, Cunha C, Barbosa MA, Calin GA, Santos SG.

Theranostics. 2018 Jun 24;8(14):3902-3917. doi: 10.7150/thno.24444. eCollection 2018.

43.

Epigenetics of gastrointestinal diseases: notes from a workshop.

Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME.

Epigenetics. 2018;13(4):449-457. doi: 10.1080/15592294.2018.1464351. Epub 2018 Jul 30.

44.

MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.

Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A.

Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707. eCollection 2018 Jul 3.

45.

Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways.

Abruzzo LV, Herling CD, Calin GA, Oakes C, Barron LL, Banks HE, Katju V, Keating MJ, Coombes KR.

Haematologica. 2018 Dec;103(12):2069-2078. doi: 10.3324/haematol.2018.190132. Epub 2018 Jul 5.

46.

Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.

Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B.

Breast Cancer Res Treat. 2018 Oct;171(3):593-605. doi: 10.1007/s10549-018-4847-2. Epub 2018 Jul 3.

PMID:
29971628
47.

Key questions about the checkpoint blockade-are microRNAs an answer?

Dragomir M, Chen B, Fu X, Calin GA.

Cancer Biol Med. 2018 May;15(2):103-115. doi: 10.20892/j.issn.2095-3941.2018.0006.

48.

Using microRNA Networks to Understand Cancer.

Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA.

Int J Mol Sci. 2018 Jun 26;19(7). pii: E1871. doi: 10.3390/ijms19071871. Review.

49.

Circular RNAs in Cancer - Lessons Learned From microRNAs.

Dragomir M, Calin GA.

Front Oncol. 2018 May 28;8:179. doi: 10.3389/fonc.2018.00179. eCollection 2018. Review. Erratum in: Front Oncol. 2018 Sep 21;8:307.

50.

Clinical utility of circulating non-coding RNAs - an update.

Anfossi S, Babayan A, Pantel K, Calin GA.

Nat Rev Clin Oncol. 2018 Sep;15(9):541-563. doi: 10.1038/s41571-018-0035-x. Review.

PMID:
29784926

Supplemental Content

Loading ...
Support Center